Vera Dobelmann

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis.

Inflammation reprograms fibro-adipogenic progenitors to sustain immunopathogenic niches in myositis.

Journal: Cell death & disease
Published: February 09, 2026

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

Journal: Journal of neuromuscular diseases
Published: January 16, 2026

The p.(Leu97Ile) variant expands the genetic landscape of NEFL-associated Charcot-Marie-tooth neuropathies.

The p.(Leu97Ile) variant expands the genetic landscape of NEFL-associated Charcot-Marie-tooth neuropathies.

Journal: Human molecular genetics
Published: November 18, 2025

Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology.

Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology.

Journal: Acta neuropathologica communications
Published: November 10, 2025

Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkers.

Exploring molecular signatures in PURA syndrome using muscle proteomics and serum biomarkers.

Journal: Journal of neurology
Published: September 17, 2025

Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient.

Co-occurrence of myositis and neuropathy after anti-CD30 therapy in a late-adolescent Hodgkin lymphoma patient.

Journal: Acta neuropathologica communications
Published: April 21, 2025

Flecainide mediated sodium channel blockade enhances blood brain barrier integrity and promotes neuroprotection in neuroinflammation.

Flecainide mediated sodium channel blockade enhances blood brain barrier integrity and promotes neuroprotection in neuroinflammation.

Journal: Scientific reports
Published: October 30, 2024

Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle.

Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscle.

Journal: Brain : a journal of neurology
Published: October 27, 2024

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy.

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy.

Journal: Journal of neurology
Published: May 31, 2024

Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.

Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.

Journal: EBioMedicine
Published: March 04, 2024

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.

Journal: Acta neuropathologica
Published: February 15, 2024

Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice.

Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice.

Journal: Cells
Published: January 28, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026